The Trust Research, Development, and Innovation (RD&I) Integrated Performance Report summarises and provides an update of activities of the Trust’s RD&I service for each quarter of the financial year.
The report reflects the RD&I strategic priorities published in the Velindre University NHS Trust’s Integrated Medium-Term Plan (IMTP). These priorities support the Trust’s strategic goal to be “A beacon for research, development and innovation” are as follows:
Strategic Priorities
| Priority 1 | The Trust will drive forward the implementation of its Cancer Research and Development Ambitions 2022-2031 |
| Priority 2 | The Trust will maximise the Research and Development ambitions of the Welsh Blood Service |
| Priority 3 |
The Trust will implement the Velindre Innovation Plan |
| Priority 4 | The Trust will maximise collaborative opportunities locally, nationally, and internationally |
The report provides an update of activities against the Trust RD&I service’s strategic priorities, alongside the supporting work of cross‑cutting themes and corporate functions that support research, development, and innovation.
The reports for quarters one through three summarise the work in that quarter, culminating in an annual report (incorporating quarter four) at the end of the financial year.